Company intelligence
Critical Path Institute (C-Path)
Advancing Drug Development. Improving Lives. Together.
About Critical Path Institute (C-Path)
Critical Path Institute (C-Path) is an independent, nonprofit established in 2005 as a public-private partnership, in response to the FDA’s Critical Path Initiative. C-Path’s mission is to lead collaborations that advance better treatments for people worldwide. Globally recognized as a pioneer in accelerating drug development, C-Path has established numerous international consortia, programs and initiatives that currently include more than 1,600 scientists and representatives from government and regulatory agencies, academia, patient organizations, disease foundations and pharmaceutical and biotech companies. With dedicated team members located throughout the world, C-Path’s global headquarters is located in Tucson, Arizona and C-Path’s Europe subsidiary is headquartered in Amsterdam, Netherlands. For more information, visit c-path.org.
Verified activity
Signals from Critical Path Institute (C-Path)
7 published signals
Presence & Recognition
Critical Path Institute (C-Path) hosted the Global Impact Conference 2026 featuring three days of high-impact dialogue and collaboration focused on accelerating better treatments for patients worldwide.
Reported by Critical Path Institute (C-Path)
Research & Knowledge
Critical Path Institute (C-Path) researchers are closer than ever to developing the first targeted treatments for Autosomal Dominant Tubulointerstitial Kidney Disease caused by UMOD and MUC1 gene variants.
Reported by Critical Path Institute (C-Path)
Presence & Recognition
Critical Path Institute (C-Path) hosted the Global Impact Conference 2026 featuring three days of high-impact dialogue and collaboration focused on accelerating better treatments for patients worldwide.
Reported by Critical Path Institute (C-Path)
Presence & Recognition
Critical Path Institute (C-Path) released the newest episode of the Critical Path Institute Podcast exploring collaboration between patients, researchers, regulators, and drug developers for neuromuscular drug development.
Reported by Critical Path Institute (C-Path)
Presence & Recognition
Critical Path Institute (C-Path) hosted a session titled Imaging the Invisible: Neuroimaging Biomarkers as Catalysts for Early-Stage Drug Development at the C-Path Global Impact Conference in Washington, D.C., on September 16.
Reported by Critical Path Institute (C-Path)
Presence & Recognition
Critical Path Institute (C-Path) is participating in the 2026 American Conference on Pharmacometrics, an International Conference on Pharmacometrics in the U.S., taking place October 11–14, 2026, at the Gaylord National Resort & Convention Center in National Harbor, Maryland.
Reported by Critical Path Institute (C-Path)
Presence & Recognition
Critical Path Institute (C-Path) hosted a Public Private Partnerships for Rare Neurodegenerative Disease webinar bringing together federal partners, researchers, advocates, and members of the ALS lived-experience community.
Reported by Critical Path Institute (C-Path)